カテゴリー： 世界, Grand View Research

細胞培養培地の世界市場2025-2030

【英語タイトル】Cell Culture Media Market Size, Share & Trends Analysis Report By Product (Serum-free Media, Classical Media), By Type (Liquid Media, Semi-solid And Solid Media), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

Grand View Researchが出版した調査資料（GVR553FG4423）・商品コード：GVR553FG4423
・発行会社（調査会社）：Grand View Research
・発行日：2025年1月
・ページ数：約140
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Individual License（1名様閲覧用）USD5,950 ⇒換算￥856,800見積依頼/購入/質問フォーム
Team License（5名様閲覧用）USD6,950 ⇒換算￥1,000,800見積依頼/購入/質問フォーム
Enterprise License（閲覧人数無制限）USD8,950 ⇒換算￥1,288,800見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

2024年の世界の細胞培養培地市場規模は約43億ドルと推定され、2030年には約84億ドルに達すると予測されており、2025年から2030年にかけての年平均成長率（CAGR）は12.2%とされています。細胞培養培地は、バイオ医薬品の製造において不可欠な成分であり、細胞や微生物の成長を支えるためのゲル状または液体の溶液です。北米市場が2024年時点で世界市場の38.16%を占め、特に米国が主要市場となっています。製品別では血清不使用培地（Serum-free media）が36.06%と最大シェアを持ち、用途別ではバイオ医薬品生産分野が47.65%を占めています。タイプ別では液体培地が最も高い収益を上げています。

COVID-19の流行は、細胞ベースのワクチン技術への需要を高め、Vero細胞などを用いたワクチン開発が活発化しました。また、アデノ随伴ウイルス（AAV）ベクターの細胞培養による製造も加速しており、これがワクチンや遺伝子治療の有効な手段として注目されています。大手企業ではSartoriusがパンデミック下で全地域における生産能力を拡大し、需要に対応しました。また、バイオシミラー市場の拡大も今後の成長要因となっており、主要バイオ医薬品の特許切れを受けて市場が活発化しています。

製品面では、血清不使用培地の採用が進んでおり、感染リスクの低減や再現性の向上、動物由来成分の回避が評価されています。特に幹細胞研究や個別化医療の分野での需要が増しており、FDAの規制要件強化もこれを後押ししています。幹細胞用培地も今後大きな成長が期待されており、再生医療や創薬研究における応用拡大が背景にあります。

応用分野では、バイオ医薬品生産が最も市場を牽引しており、より高品質かつ再現性のある培地の需要が高まっています。診断分野でも慢性疾患の増加と技術革新により細胞培養培地の活用が進んでいます。タイプ別では液体培地の需要が拡大しており、粉末からの切り替えが進む中、製造工程の簡略化や安全性向上が評価されています。

エンドユーザー別では、製薬・バイオテクノロジー企業が最も大きなシェアを占めており、生産拠点の拡張が需要をさらに押し上げています。たとえば、Sartorius Stedim Biotechは2024年に米国マールボロに新しいバイオプロセス研究センターを開設し、2025年にはGMP対応の製造スイートも追加予定です。

市場は急成長段階にあり、技術革新、バイオ医薬品や再生医療分野での応用拡大、地域的拡張、M&Aの活発化により、競争と進化が同時に進んでいます。主要企業にはSartorius、Danaher、Merck、Thermo Fisher、富士フイルム、Lonzaなどがあり、業界の動向を主導しています。今後も規制対応、高品質化、地域展開を中心に市場はさらなる成長が見込まれます。

The Global Cell Culture Media market size was estimated at USD 4,307.1 million in 2024 and is projected to reach USD 8,430.2 million by 2030, growing at a CAGR of 12.2% from 2025 to 2030.Cell culture media is generally a gel or liquid including compounds required to regulate and support the growth of cells or microorganisms used in the manufacturing of biopharmaceuticals.

Key Market Trends & Insights
• North America cell culture media market dominated the industry with a share of 38.16% in 2024.
• The U.S. cell culture media market held the largest share in North America in 2024.
• By product, the serum-free media segment held the highest share of 36.06% of the market in 2024.
• By application, the biopharmaceutical production segment dominated the market with a share of 47.65% in 2024.
• By type, the liquid media segment captured the higher revenue share in 2024.

Market Size & Forecast
• 2024 Market Size: USD 4,307.1 Million
• 2030 Projected Market Size: USD 8,430.2 Million
• CAGR (2025-2030): 12.2%
• North America: Largest market in 2024

Culture media is a critical ingredient in biopharmaceutical manufacturing, aiding the growth of cells, and is the fastest-growing segment within this market. Fast growth is mainly driven by growing demand for biopharmaceuticals, favorable governmental policies, and increasing investment in R&D.To learn more about this report, request a free sample copy
The outbreak of the COVID-19 pandemic has improved demand for well-established cell-based vaccine production technologies. Moreover, it has given rise to a few scientific innovations, particularly in the production and testing of vaccine technology. For instance, the Vero cell line originated from the African green monkey kidney and has been extensively used for viral vaccine manufacturing. It has also been used for the development of various SARS-CoV variants. ProVeroTM1 Serum-free Medium manufactured by Lonza Bioscience is a protein-free medium of non-animal origin designed to support the growth of Vero cells and MDCK.
Furthermore, cell culture produced AAV vectors have also gained thrust as one of the most effective protein and gene delivery tools in vaccine manufacturing as well as gene therapy. Additionally, key market players are expanding their production capabilities. For instance, in 2021, Sartorius increased its production in all regions due to elevated demand in its core business and to additional customer needs related to COVID-19 therapeutics and COVID-19 vaccines.
The biosimilar market is on the cusp of momentous growth. This growth is, in large part, due to several mAb biosimilars that are anticipated to be launched in a few years as patents on significant drugs, such as trastuzumab (Herceptin from Roche), infliximab (Remicade from J&J), and Adalimumab (Humira from Abbott), are going to expire.
Additionally, the FDA’s approval of cell-based candidate vaccine viruses (CVVs) for use in cell-based influenza vaccines could advance the efficiency of cell-based flu vaccines. Cell culture technology has been used to develop other U.S.-licensed vaccines, comprising vaccines for smallpox, rotavirus, rubella, hepatitis chickenpox, and polio. Furthermore, for the 2021-2022 influenza season, all four flu viruses used in the cell-based vaccine are cell-derived. For instance, in October 2021, Seqirus received U.S. FDA approval for FLUCELVAX QUADRIVALENT, the first and only cell-based influenza vaccine in the U.S.

Market Concentration & Characteristics
The cell culture media industry is in a high-growth stage, with its pace accelerating due to rising demand from biopharma, diagnostics, and research sectors. The market is characterized by rapid advancements in media formulations, increased investments in biotechnological research, and expanding applications in drug development, regenerative medicine, and personalized therapies. Competitive dynamics and innovation are also driving new product launches and collaborations among key players.

The industry is experiencing a high level of mergers and acquisitions (M&A) activity, driven by the need for market consolidation and the expansion of product portfolios. Key players are acquiring smaller companies to enhance their capabilities, gain access to advanced technologies, and expand their global reach. These strategic moves are also helping companies address increasing demand from the biopharma, diagnostics, and research sectors while staying competitive in a rapidly growing market.

Regulations significantly impact the cell culture media industry, influencing product development, manufacturing processes, and market approvals. Strict guidelines ensure the safety, quality, and efficacy of cell culture media used in biopharma, diagnostics, and research applications. Compliance with these regulations, such as GMP and ISO standards, is critical for market players. Additionally, regulatory updates and regional differences can affect product timelines and market entry strategies, making adherence essential for sustained growth.
The cell culture media industry has experienced exponential growth, driven by the rising demand for more effective treatments. This growth is attributed to advancements in biologics, increasing adoption of cell-based therapies, and growing research in regenerative medicine and drug discovery. The need for high-quality media to support cell viability and functionality, along with expanding biopharma and healthcare applications, further accelerates market expansion.
The cell culture media industry is experiencing significant regional expansion as service providers strategically establish their presence in new geographic areas. This growth is attributed to increasing demand for cell culture products in emerging markets, growing biopharma activities, and expanding healthcare infrastructure. Companies are targeting regions with rising research investments and favorable regulatory environments to tap into new opportunities and enhance their global footprint.

Product Insights
The serum-free media segment held the highest share of 36.06% of the market in 2024. The use of SFM signifies a significant tool, which allows the researchers to perform specific applications or grow a specific cell type without using serum. Advantages of using SFM include increased growth and/or productivity, more consistent performance, better control over physiological sensitivity, and diminishing the risk of infection by serum-borne adventitious agents in the culture. In addition, serum-free alternatives better serve animal welfare which is the major factor driving the adoption of SFM. In addition, the field of gene and cell therapy is rapidly growing, and the Food and Drug Administration regulatory guidelines are demanding more control of raw materials to sustain the reliable and safe manufacturing of drug products. The use of SFM offers an opportunity to produce additional reproducible formulations and fewer batch-to-batch variability.
The stem cell culture media segment is expected to grow significantly during the forecast period due to increasing investments in stem cell research and its expanding applications in regenerative medicine, drug discovery, and personalized medicine. Additionally, advancements in media formulations to enhance stem cell viability and functionality, along with rising demand from research institutions and biopharma companies, are driving this growth.

Application Insights
The biopharmaceutical production segment dominated the market with a share of 47.65% in 2024. The biopharmaceutical industry’s demand for more reproducible and better-defined media to meet the expanding production levels while reducing the risk of contamination in the downstream processes is significantly increasing the demand for this market. Moreover, strategic activities by key biopharmaceutical companies also drive the segment growth. For instance, in July 2023, Sartorius AG announced an investment of USD 33 million to expand their new cell culture media manufacturing facility at their site in Yauco, Puerto Rico.
The diagnostics segment is expected to grow at a significant CAGR during the forecast period, driven by the increasing use of cell culture media in diagnostic applications such as disease detection and monitoring. The rising prevalence of chronic diseases, advancements in diagnostic technologies, and growing demand for accurate and early disease diagnosis are key factors contributing to this growth.

Type Insights
The liquid media segment captured the higher revenue share in 2024. An increasing number of biologics and biosimilars manufacturers, both downstream and upstream, are switching from premixed powders to liquid media owing to factors such as rapid mycobacterial growth and high rate of isolation. Moreover, it eradicates a few process steps, and also reduces the probability of hazardous exposure, and makes manufacturing and development more flexible and simpler than powdered media. In addition, ready-to-use liquid media also eliminates the need for mixing containers, balances, and installation of water for injection (WFI) loop, which is needed for mixing powder media.
The segment is also being driven by the manufacturers’ strategic activities. For instance, in June 2023, Gold Standard Diagnostics launched BACGroM Culture Media, designed to identify pathogenic microorganisms in the food, environmental, and pharmaceutical industries. The BACGro line includes premium dehydrated and liquid media products that meet global standards.

The semi-solid and solid media segment is expected to grow at a significant CAGR during the forecast period, driven by its increasing use in microbial culture, stem cell research, and drug development. For instance, in December 2024, BioCentriq announced its expansion into a new cell therapy manufacturing facility in Princeton, NJ, reflecting the rising demand for advanced bioprocessing solutions. Advancements in media formulations and the rising demand for efficient tools in cell-based assays and biopharma applications further support the segment’s growth.

End-use Insights
The pharmaceutical & biotechnology companies segment captured the highest revenue share of 34.39% in 2024. The expansion of the current manufacturing capacities for biopharmaceuticals drives the demand for cell culture products. For instance, in November 2024, Sartorius Stedim Biotech opened a new Center for Bioprocess Innovation in Marlborough, USA. The facility offers research labs and process development services to support next-generation therapeutics, including upstream and downstream process optimization, proof-of-concept runs, demos, and customer training. By 2025, the center will add two GMP suites for novel manufacturing processes.

Key Cell Culture Media Companies:
The following are the leading companies in the cell culture media market. These companies collectively hold the largest market share and dictate industry trends.
• Sartorius AG
• Danaher
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• FUJIFILM Corporation
• Lonza
• BD
• STEMCELL Technologies
• Cell Biologics, Inc.
• PromoCell GmbH

❖ レポートの目次 ❖

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Type
1.2.4. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Impact Analysis
3.3.1.1. Expansion of biosimilars and biologics
3.3.1.2. Growth in stem cell research
3.3.1.3. Emerging cell culture technologies for cell-based vaccines
3.3.2. Market Restraint Impact Analysis
3.3.2.1. Ethical issues concerning the use of animal-derived products
3.3.2.2. Stringent regulatory guidelines
3.4. Business Environment Analysis
3.4.1. PESTLE Analysis
3.4.2. PORTER’S Five Forces Analysis
3.4.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Product Segment Dashboard
4.2. Global Cell Culture Media Market Product, Movement Analysis
4.3. Global Cell Culture Media Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Serum-free Media
4.4.1. Global serum-free media market estimates and forecasts, 2018 – 2030 (USD Million)
4.4.2. CHO Media
4.4.2.1. Global CHO media market estimates and forecasts, 2018 – 2030 (USD Million)
4.4.3. HEK 293 media
4.4.3.1. Global HEK 293 media market estimates and forecasts, 2018 – 2030 (USD Million)
4.4.4. BHK media
4.4.4.1. Global BHK media market estimates and forecasts, 2018 – 2030 (USD Million)
4.4.5. Vero medium
4.4.5.1. Global vero medium market estimates and forecasts, 2018 – 2030 (USD Million)
4.4.6. Other serum-free media
4.4.6.1. Global other serum-free media market estimates and forecasts, 2018 – 2030 (USD Million)
4.5. Classical Media
4.5.1. Global classical media market estimates and forecasts, 2018 – 2030 (USD Million)
4.6. Stem Cell Culture Media
4.6.1. Global stem cell culture media market estimates and forecasts, 2018 – 2030 (USD Million)
4.7. Chemically Defined Media
4.7.1. Global chemically defined media market estimates and forecasts, 2018 – 2030 (USD Million)
4.8. Specialty Media
4.8.1. Global speciality media market estimates and forecasts, 2018 – 2030 (USD Million)
4.9. Other Cell Culture Media
4.9.1. Global other cell culture media market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 5. Type Business Analysis
5.1. Type Segment Dashboard
5.2. Global Cell Culture Media Market Type, Movement Analysis
5.3. Global Cell Culture Media Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
5.4. Liquid Media
5.4.1. Global liquid media market estimates and forecasts, 2018 – 2030 (USD Million)
5.5. Semisolid & Solid Media
5.5.1. Global semi-solid & solid media market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. Application Segment Dashboard
6.2. Global Cell Culture Media Market Application, Movement Analysis
6.3. Global Cell Culture Media Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Biopharmaceutical Production
6.4.1. Global biopharmaceutical production market estimates and forecasts, 2018 – 2030 (USD Million)
6.4.2. Monoclonal antibodies
6.4.2.1. Global monoclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
6.4.3. Vaccines production
6.4.3.1. Global vaccines production market estimates and forecasts, 2018 – 2030 (USD Million)
6.4.4. Other therapeutic proteins
6.4.4.1. Global other therapeutic proteins market estimates and forecasts, 2018 – 2030 (USD Million)
6.5. Diagnostics
6.5.1. Global diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)
6.6. Drug Screening & Development
6.6.1. Global drug screening & development market estimates and forecasts, 2018 – 2030 (USD Million)
6.7. Tissue Engineering & Regenerative Medicine
6.7.1. Global tissue engineering & regenerative medicine market estimates and forecasts, 2018 – 2030 (USD Million)
6.7.2. Cell & gene therapy
6.7.2.1. Global cell & gene therapy market estimates and forecasts, 2018 – 2030 (USD Million)
6.7.3. Other tissue engineering & regenerative medicine
6.7.3.1. Global other tissue engineering & regenerative medicine market estimates and forecasts, 2018 – 2030 (USD Million)
6.8. Other Applications
6.8.1. Global other applications market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 7. End Use Business Analysis
7.1. End Use Segment Dashboard
7.2. Global Cell Culture Media Market End Use, Movement Analysis
7.3. Global Cell Culture Media Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Global pharmaceutical & biotechnology companies market estimates and forecasts, 2018 – 2030 (USD Million)
7.5. Hospitals & Diagnostic Laboratories
7.5.1. Global hospitals & diagnostic laboratories market estimates and forecasts, 2018 – 2030 (USD Million)
7.6. Research & Academic Institutes
7.6.1. Global research & academic institutes market estimates and forecasts, 2018 – 2030 (USD Million)
7.7. Other End Use
7.7.1. Global other end user market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 8. Cell Culture Media Market: Regional Estimates and Trend Analysis, by Product, Type, Application, & End-Use
8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
8.3. North America
8.3.1. North America cell culture media market, 2018 – 2030 (USD Million)
8.3.2. U.S.
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. U.S. cell culture media market, 2018 – 2030 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Canada cell culture media market, 2018 – 2030 (USD Million)
8.3.4. Mexico
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Mexcio cell culture media market, 2018 – 2030 (USD Million)
8.4. Europe
8.4.1. Europe cell culture media market, 2018 – 2030 (USD Million)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. UK cell culture media market, 2018 – 2030 (USD Million)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Germany cell culture media market, 2018 – 2030 (USD Million)
8.4.4. France
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. France cell culture media market, 2018 – 2030 (USD Million)
8.4.5. Italy
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Italy cell culture media market, 2018 – 2030 (USD Million)
8.4.6. Spain
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Spain cell culture media market, 2018 – 2030 (USD Million)
8.4.7. Denmark
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Denmark cell culture media market, 2018 – 2030 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Sweden cell culture media market, 2018 – 2030 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Framework
8.4.9.4. Norway cell culture media market, 2018 – 2030 (USD Million)
8.5. Asia Pacific
8.5.1. Asia Pacific cell culture media market, 2018 – 2030 (USD Million)
8.5.2. Japan
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Japan cell culture media market, 2018 – 2030 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. China cell culture media market, 2018 – 2030 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. India cell culture media market, 2018 – 2030 (USD Million)
8.5.5. Singapore
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Singapore cell culture media market, 2018 – 2030 (USD Million)
8.5.6. Australia
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Australia cell culture media market, 2018 – 2030 (USD Million)
8.5.7. Thailand
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Thailand cell culture media market, 2018 – 2030 (USD Million)
8.5.8. South Korea
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. South Korea cell culture media market, 2018 – 2030 (USD Million)
8.6. Latin America
8.6.1. Latin America cell culture media market, 2018 – 2030 (USD Million)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Brazil cell culture media market, 2018 – 2030 (USD Million)
8.6.3. Argentina
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Argentina cell culture media market, 2018 – 2030 (USD Million)
8.7. MEA
8.7.1. MEA cell culture media market, 2018 – 2030 (USD Million)
8.7.2. South Africa
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. South Africa cell culture media market, 2018 – 2030 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Saudi Arabia cell culture media market, 2018 – 2030 (USD Million)
8.7.4. UAE
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. UAE cell culture media market, 2018 – 2030 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Kuwait cell culture media market, 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Sartorius AG
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Danaher
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Merck KGaA
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Thermo Fisher Scientific, Inc.
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. FUJIFILM Corporation
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Lonza
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. BD
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. STEMCELL Technologies
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Cell Biologics, Inc.
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. PromoCell GmbH
9.4.10.1. Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives

 

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 4. Global Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 5. Global Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 6. Global Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 7. Global Cell Culture Media Market, by Region, 2018 – 2030 (USD Million)
Table 8. North America Cell Culture Media Market, by Country, 2018 – 2030 (USD Million)
Table 9. North America Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 10. North America Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 11. North America Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 12. North America Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 13. U.S. Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 14. U.S. Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 15. U.S. Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 16. U.S. Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 17. Canada Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 18. Canada Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 19. Canada Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 20. Canada Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 21. Mexico Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 22. Mexico Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 23. Mexico Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 24. Mexico Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 25. Europe Cell Culture Media Market, by Country, 2018 – 2030 (USD Million)
Table 26. Europe Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 27. Europe Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 28. Europe Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 29. Europe Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 30. Germany Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 31. Germany Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 32. Germany Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 33. Germany Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 34. UK Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 35. UK Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 36. UK Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 37. UK Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 38. France Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 39. France Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 40. France Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 41. France Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 42. Italy Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 43. Italy Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 44. Italy Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 45. Italy Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 46. Spain Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 47. Spain Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 48. Spain Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 49. Spain Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 50. Denmark Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 51. Denmark Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 52. Denmark Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 53. Denmark Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 54. Norway Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 55. Norway Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 56. Norway Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 57. Norway Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 58. Sweden Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 59. Sweden Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 60. Sweden Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 61. Sweden Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 62. Asia Pacific Cell Culture Media Market, by Country, 2018 – 2030 (USD Million)
Table 63. Asia Pacific Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 64. Asia Pacific Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 65. Asia Pacific Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 66. Asia Pacific Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 67. China Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 68. China Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 69. China Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 70. China Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 71. Japan Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 72. Japan Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 73. Japan Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 74. Japan Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 75. India Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 76. India Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 77. India Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 78. India Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 79. South Korea Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 80. South Korea Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 81. South Korea Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 82. South Korea Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 83. Australia Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 84. Australia Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 85. Australia Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 86. Australia Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 87. Thailand Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 88. Thailand Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 89. Thailand Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 90. Thailand Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 91. Latin America Cell Culture Media Market, by Country, 2018 – 2030 (USD Million)
Table 92. Latin America Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 93. Latin America Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 94. Latin America Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 95. Latin America Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 96. Brazil Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 97. Brazil Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 98. Brazil Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 99. Brazil Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 100. Argentina Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 101. Argentina Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 102. Argentina Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 103. Argentina Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 104. Middle East and Africa Cell Culture Media Market, by Country, 2018 – 2030 (USD Million)
Table 105. Middle East and Africa Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 106. Middle East and Africa Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 107. Middle East and Africa Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 108. Middle East and Africa Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 109. South Africa Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 110. South Africa Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 111. South Africa Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 112. South Africa Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 113. Saudi Arabia Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 114. Saudi Arabia Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 115. Saudi Arabia Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 116. Saudi Arabia Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 117. UAE Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 118. UAE Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 119. UAE Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 120. UAE Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)
Table 121. Kuwait Cell Culture Media Market, by Product, 2018 – 2030 (USD Million)
Table 122. Kuwait Cell Culture Media Market, by Type, 2018 – 2030 (USD Million)
Table 123. Kuwait Cell Culture Media Market, by Application, 2018 – 2030 (USD Million)
Table 124. Kuwait Cell Culture Media Market, by End-use, 2018 – 2030 (USD Million)



★調査レポート[細胞培養培地の世界市場2025-2030] (コード：GVR553FG4423)販売に関する免責事項を必ずご確認ください。
★調査レポート[細胞培養培地の世界市場2025-2030]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 細胞＆遺伝子治療CDMO市場-規模、シェア、動向分析レポート、予測2024-2030
  • 脳磁図検査の世界市場2025-2030
  • 日本の医薬品開発製造受託機関（CDMO）市場規模、シェア、動向分析レポート、予測2023-2030
  • 医療機器リサイクルサービスの世界市場2024-2030
  • ビデオ管理システム（VMS）の世界市場2024-2030
  • Global Digital Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
  • アルミダイカストマシンの世界市場2024-2030
  • Global Electronic Load Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
  • 標的タンパク質分解市場2020-2030
  • 細胞培養培地の世界市場（～2032年）

    • ◆H&Iグローバルリサーチのお客様（例）◆